SAM ACTION, INC. for SAM ACTION, INC.

Health Issues HCR

the effects of marijuana on children, pregnant women and developing brains, the nexus between high potency marijuana and mental illness

Contacted: SENATE; Natl Institutes of Health (NIH); Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Small Business Administration (SBA); Office of Natl Drug Control Policy (NDCP); White House Office; Justice, Dept of (DOJ)

Government Issues GOV

federal role in marijuana laws, the legalization of marijuana, criminal justice reform

Contacted: Justice, Dept of (DOJ); White House Office; Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); SENATE; Office of Natl Drug Control Policy (NDCP); Small Business Administration (SBA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Law Enforcement/Crime/Criminal Justice LAW

H.R. 2093/S. 1028, STATES Act to legalize marijuana, appropriations amendments related to marijuana legalization, criminal justice reform related to marijuana, H.R. 3884, MORE Act.

Contacted: Natl Institutes of Health (NIH); White House Office; Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Small Business Administration (SBA); SENATE; Drug Enforcement Administration (DEA)

Bills named: H.R. 3884 (116th), S. 1028 (116th), H.R. 2093 (116th)

Banking BAN

H.R. 1595/S. 1200, SAFE Banking Act on marijuana banking and investment

Contacted: White House Office; SENATE; Small Business Administration (SBA); Office of Natl Drug Control Policy (NDCP); Drug Enforcement Administration (DEA); Natl Institutes of Health (NIH); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 1200 (116th), H.R. 1595 (116th)

Consumer Issues/Safety/Products CSP

safety issues surrounding marijuana, marketing of high potency marijuana products to children

Contacted: Drug Enforcement Administration (DEA); Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP); Food & Drug Administration (FDA); SENATE; White House Office; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Small Business Administration (SBA)

Medical/Disease Research/Clinical Labs MED

H.R. 3797, Medical Marijuana Research Act, S. 2032, Cannabidiol and Marihuana Research Expansion Act, to lower the barriers of researching marijuana

Contacted: Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Small Business Administration (SBA); SENATE; White House Office; Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); Justice, Dept of (DOJ)

Bills named: S. 2032 (116th), H.R. 3797 (116th)

Small Business SMB

Preventing federally illegal enterprises from gaining a special carve out to access federally subsidized loans or grants.

Contacted: Natl Institutes of Health (NIH); Drug Enforcement Administration (DEA); SENATE; Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Food & Drug Administration (FDA); Small Business Administration (SBA); White House Office

Alcohol and Drug Abuse ALC

The effects of marijuana on children, the nexus between marijuana and psychosis

Contacted: Office of Natl Drug Control Policy (NDCP); White House Office; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); SENATE; Drug Enforcement Administration (DEA); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Small Business Administration (SBA)